Accretion Nutraveda Limited is engaged in the manufacturing of Ayurvedic and Nutraceutical products across a wide range of dosage forms, including tablets, capsules, oral liquids, oral powders, medicated oils, and external preparations such as balms, creams, ointments, and gels.
The company operates as a Contract Development and Manufacturing Organization (CDMO), providing end-to-end manufacturing solutions to healthcare and wellness brands. Its offerings integrate classical Ayurvedic formulations with modern nutraceutical science, addressing multiple therapeutic and wellness segments such as liver care, women’s health, bone and joint health, cognitive support, respiratory care, digestive health, skin and hair care, and paediatric wellness.
Accretion Nutraveda operates through two primary business verticals:
- Domestic Sales & Merchant Exports (Loan License Basis): This is the company’s core revenue driver, contributing 96.62% of total revenue in FY 2024-25.
- Direct Exports: Accounts for a smaller but growing share of revenue, contributing 3.38% in FY 2024-25, with exports to countries such as Sri Lanka, Singapore, and the USA.
The company operates a 10,763 sq. ft. leased manufacturing facility in Gujarat, equipped with 13 AHUs with HEPA filtration, segregated processing areas, and robust quality control systems for Ayurvedic and nutraceutical production.
Accretion Nutraveda’s manufacturing facility complies with stringent quality standards and holds GMP (AYUSH), WHO-GMP, FSSC 22000, ISO 9001:2015, ISO 45001:2018, Halal certification, and an FSSAI license.
Accretion Nutraveda IPO – Details
| IPO Opening Date | 28 January 2026 |
| IPO Closing Date | 30 January 2026 |
| Issue Type | Book Built Issue IPO |
| Issue Size | Total Issue: 19,20,000 Shares Worth ₹24.77 Crore Fresh Issue: 19,20,000 Shares Worth ₹24.77 Crore |
| Face Value | ₹10 per equity share |
| IPO Price | ₹122 – ₹129 per share |
| Market Lot | 1000 Shares |
| Min Order | 1000 Shares [ 1 Lot ] |
| Listing At | BSE SME |
| Registrar | Kfin Technologies Ltd. |
| QIB Shares Offered | 50% |
| NII Shares Offered | 15% |
| Retail Shares Offered | 35% |
Accretion Nutraveda IPO – Date Schedule
| IPO Open Date | 28 January 2026 |
| IPO Close Date | 30 January 2026 |
| Basis of Allotment | 02 February 2026 |
| Initiation of Refund | 03 February 2026 |
| Credit of Shares to Demat | 03 February 2026 |
| IPO Listing Date | 04 February 2026 |
| Cut-off time for UPI mandate confirmation | 5 PM on January 30, 2026 |
Accretion Nutraveda IPO – Lots Size & Price
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2000 | ₹2,58,000 |
| Retail (Max) | 2 | 2000 | ₹2,58,000 |
| S-HNI (Min) | 3 | 3000 | ₹3,87,000 |
| S-HNI (Max) | 7 | 7000 | ₹9,03,000 |
| B-HNI (Min) | 8 | 8000 | ₹10,32,000 |
Competitive Strength
- Experienced promoters and management Team.
- Diverse product portfolio.
- Commitment to quality standards.
- Relationships with clients and suppliers.
- Established business process and management framework.
Company Promoters
- Mr. Mayur Popatlal Sojitra
- Mr. Ankurkumar Shantilal Patel
- Mr. Paraskumar Vinubhai Parmar
- Mr. Hardik Mukundbhai Prajapati
- Mr. Harshad Nanubhai Rathod
- Mr. Vivek Ashok Kumar Patel
Company Financials
| Period | Total Revenue | Total Expense | Profit After Tax | Total Borrowings |
|---|---|---|---|---|
| 31 March 2023 | ₹3.07 Cr | ₹2.78 Cr | ₹0.28 Cr | ₹1.97 Cr |
| 31 March 2024 | ₹5.20 Cr | ₹4.28 Cr | ₹0.82 Cr | ₹2.17 Cr |
| 31 March 2025 | ₹16.06 Cr | ₹12.87 Cr | ₹2.61 Cr | ₹3.86 Cr |
| 30 September 2025 | ₹14.07 Cr | ₹11.20 Cr | ₹2.33 Cr | ₹4.43 Cr |
Key Performance Indicator
| KPI | Values (Sep 30, 2025) |
|---|---|
| ROE | 68.54% |
| ROCE | 49.09% |
| Debt/Equity | 0.54 |
| RoNW | 56.50% |
| PAT Margin | 16.59 |
| EBITDA Margin | 23.36 |
| Price to Book Value | 7.71 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 4.91 | 6.44 |
| P/E (x) | 26.27 | 20.02 |
Object Of The Issue
| Objects of the Issue | Expected Amount (in Crore) |
|---|---|
| Purchase of machinery for Automation in the existing Manufacturing unit. | ₹4.22 |
| Purchase of Machinery for New Manufacturing Setup. | ₹8.03 |
| Funding the working capital requirements of the company. | ₹5.50 |
| General corporate purposes. | – |
✅Strengths
- CDMO model with diversified Ayurvedic & nutraceutical product range.
- Multiple dosage forms (tablets, capsules, liquids, powders, externals).
- Strong certifications (GMP, WHO-GMP, FSSC 22000, ISO, Halal, FSSAI).
- Consistent revenue & profit growth over last 3 years.
- Export presence in Sri Lanka, Singapore & USA.
- Experienced promoter & management team.
⚠️Risks
- High domestic revenue dependence (~96% of revenue).
- Customer concentration risk.
- Operations largely on loan-license basis.
- Manufacturing facility is leased.
- Strict regulatory compliance requirements.
- Highly competitive industry.
Accretion Nutraveda IPO Promoter Holding
| Pre-Issue Share Holding | 100.00% |
| Post Issue Share Holding | 73.48% |
Accretion Nutraveda IPO Prospectus
Company Contact Information
| Accretion Nutraveda Ltd. 27 Xcelon Industrial Park-1 Vasna-Chacharwadi, TaSanand, Ahmedabad, Gujarat, 382213 Phone: +91- 9904366177 Email: compliance@accretionnutraveda.com Website: https://accretionnutraveda.com/ |
Accretion Nutraveda IPO Registrar
| Kfin Technologies Ltd. Phone: 04067162222, 04079611000 Email: apl.ipo@kfintech.com Website: https://ipostatus.kfintech.com/ |
Accretion Nutraveda IPO Lead Manager(s)
| 1. Sobhagya Capital Options Ltd |
Accretion Nutraveda IPO FAQ
| What is the Accretion Nutraveda IPO? Accretion Nutraveda IPO is an SME IPO. The issue is priced at ₹122 – ₹129 per equity share. The IPO is to be listed on BSE SME. |
| When will Accretion Nutraveda IPO open? The IPO is to open on 28 January 2026 for QIB, NII, and Retail Investors. |
| What is Accretion Nutraveda IPO Investors’ Portion? The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%. |
| What is the Accretion Nutraveda IPO Size? Accretion Nutraveda IPO size is ₹24.77 Crore. |
| What are the Accretion Nutraveda IPO Minimum and Maximum Lot Sizes for Retail Investors? The minimum bid is 2000 Shares for ₹2,58,000, while the maximum bid is 2000 Shares for ₹2,58,000. |
| What is the Accretion Nutraveda IPO Allotment Date? Accretion Nutraveda IPO allotment date is 02 February 2026 |
| What is the Accretion Nutraveda IPO Listing Date? Accretion Nutraveda IPO listing date is 04 February 2026. The IPO is to be listed on the NSE SME. |
